MOLECULAR-GENETIC ANALYSIS OF OLIGODENDROGLIAL TUMORS SHOWS PREFERENTIAL ALLELIC DELETIONS ON 19Q AND 1P

被引:1
|
作者
REIFENBERGER, J
REIFENBERGER, G
LIU, L
JAMES, CD
WECHSLER, W
COLLINS, VP
机构
[1] KAROLINSKA HOSP,DEPT PATHOL,S-17176 STOCKHOLM,SWEDEN
[2] SAHLGRENS UNIV HOSP,DEPT PATHOL,GOTHENBURG,SWEDEN
[3] EMORY UNIV,DEPT NEUROSURG,MOLEC NEUROONCOL LAB,ATLANTA,GA 30322
[4] UNIV DUSSELDORF,DEPT NEUROPATHOL,W-4000 DUSSELDORF,GERMANY
[5] KAROLINSKA HOSP,LUDWIG INST CANC RES,STOCKHOLM BRANCH,S-10401 STOCKHOLM,SWEDEN
来源
AMERICAN JOURNAL OF PATHOLOGY | 1994年 / 145卷 / 05期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The moleculargenetic alterations of oligodendroglial tumors and mixed gliomas of the central nervous system were studied in a series of 37 cases (8 oligodendrogliomas, 13 anaplastic oligodendrogliomas, 8 oligoastrocytomas, and 8 anaplastic oligoastrocytomas). A total of 180 polymorphic loci and 5 nonpolymorphic gene loci, distributed over all chromosomes, were examined by restriction fragment length polymorphism analysis. Loss of heterozygosity, was most frequently observed for loci on 19q with a commonly deleted region at 19q13.2-q13.4 distal to the CYP2a gene and proximal to the D19S22 locus. The incidence of allelic loss on 19q was particularly high (81%) in oligodendroglial tumors and equal to 31% in mixed gliomas. More than 75% of the tumors with allelic deletions on 19q also showed loss of heterozygosity for loci on 1p with one tumor showing only loss of alleles distal to the NGFB gene (1p13-pter). Seven (19%) tumors had lost alleles from 17p with the deleted region including the TP53 tumor suppressor gene in all cases. Sequencing of the TP53 transcripts from exons 2 to 10, however did not reveal mutations of the remaining allele in any of these tumors. Anaplastic oligodendrogliomas and anaplastic oligoastrocytomas demonstrated an increased incidence of additional allelic losses involving most frequently chromosomes 9p and 10. Gene amplification was detected in two anaplastic tumors, affecting the epidermal growth factor receptor gene in both cases, with additional amplification of the renin gene at 1q32 in one of these cases. In total our results indicate both differences and similarities between the molecular genetic alterations in tumors with oligodendroglial and astrocytic differentiation. The loss of genetic information from 19q and 1p as well as the rarity of TP53 mutations in oligodendroglial tumors suggests that the early events in their oncogenesis are distinct from those associated with astrocytic tumors. However, similarities are indicated by the allelic losses on 9p and 10 in the anaplastic tumors, suggesting the utilization of common pathways of progression.
引用
收藏
页码:1175 / 1190
页数:16
相关论文
共 50 条
  • [21] ALLELIC LOSS AT 1P AND 19Q FREQUENTLY OCCURS IN ASSOCIATION AND MAY REPRESENT EARLY ONCOGENIC EVENTS IN OLIGODENDROGLIAL TUMORS
    BELLO, MJ
    LEONE, PE
    VAQUERO, J
    DECAMPOS, JM
    KUSAK, ME
    SARASA, JL
    PESTANA, A
    REY, JA
    INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (03) : 207 - 210
  • [22] 1p/19q chromosome deletions in metastatic oligodendroglioma
    Ryan Merrell
    L. Burton Nabors
    Arie Perry
    Cheryl Ann Palmer
    Journal of Neuro-Oncology, 2006, 80 : 203 - 207
  • [23] MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion status
    Sherman, Jonathan H.
    Prevedello, Daniel M.
    Shah, Lubdha
    Raghavan, Prashant
    Pouratian, Nader
    Starke, Robert M.
    Lopes, M. Beatriz S.
    Shaffrey, Mark E.
    Schiff, David
    ACTA NEUROCHIRURGICA, 2010, 152 (11) : 1827 - 1834
  • [24] Chromosome 1p and 19q Deletions in Glioblastoma Multiforme
    Kaneshiro, David
    Kobayashi, Taisei
    Chao, Samuel T.
    Suh, John
    Prayson, Richard A.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (06) : 512 - 516
  • [25] 1p/19q chromosome deletions in metastatic oligodendroglioma
    Merrell, Ryan
    Nabors, L. Burton
    Perry, Arie
    Palmer, Cheryl Ann
    JOURNAL OF NEURO-ONCOLOGY, 2006, 80 (02) : 203 - 207
  • [26] 1p/19q status in recurrent oligodendroglial tumors: What does it tell us?
    Lavon, I
    Zelikovitsh, B
    Fuchs, D
    Fellig, Y
    Soffer, D
    Siegal, T
    NEURO-ONCOLOGY, 2005, 7 (03) : 329 - 329
  • [27] Oligodendroglial tumors: Refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival
    Felsberg, J
    Erkwoh, A
    Sabel, MC
    Kirsch, L
    Fimmers, R
    Blaschke, B
    Schlegel, U
    Schramm, J
    Wiestler, OD
    Reifenberger, G
    BRAIN PATHOLOGY, 2004, 14 (02) : 121 - 130
  • [28] No preferential loss of paternal 19q alleles in oligodendroglial tumors
    Hartmann, C
    Mueller, W
    Lass, U
    Stockhammer, F
    von Eckardstein, K
    Veelken, J
    Jeuken, J
    Wick, W
    von Deimling, A
    ANNALS OF NEUROLOGY, 2003, 54 (02) : 256 - 258
  • [29] MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion status
    Jonathan H. Sherman
    Daniel M. Prevedello
    Lubdha Shah
    Prashant Raghavan
    Nader Pouratian
    Robert M. Starke
    M. Beatriz S. Lopes
    Mark E. Shaffrey
    David Schiff
    Acta Neurochirurgica, 2010, 152 : 1827 - 1834
  • [30] No preferential loss of paternal 19Q alleles in oligodendroglial tumors
    Hartmann, C
    Mueller, W
    Lass, U
    Stockhammer, F
    von Eckardstein, K
    Veelken, J
    Jeuken, J
    Wick, W
    von Deimling, A
    ACTA NEUROPATHOLOGICA, 2004, 108 (04) : 355 - 355